Cargando…

Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery

BACKGROUND: Visual acuity (VA) and visual field defects (VF) are evaluated in the preoperative management of non-functioning pituitary adenoma (NFPA). The former is less studied than the latter. RESEARCH QUESTION: To analyze preoperative factors, including adenoma volumetry, associated with reduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Uvelius, Erik, Valdemarsson, Stig, Bengzon, Johan, Hammar, Björn, Siesjö, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668060/
https://www.ncbi.nlm.nih.gov/pubmed/38020979
http://dx.doi.org/10.1016/j.bas.2023.102667
_version_ 1785139389385408512
author Uvelius, Erik
Valdemarsson, Stig
Bengzon, Johan
Hammar, Björn
Siesjö, Peter
author_facet Uvelius, Erik
Valdemarsson, Stig
Bengzon, Johan
Hammar, Björn
Siesjö, Peter
author_sort Uvelius, Erik
collection PubMed
description BACKGROUND: Visual acuity (VA) and visual field defects (VF) are evaluated in the preoperative management of non-functioning pituitary adenoma (NFPA). The former is less studied than the latter. RESEARCH QUESTION: To analyze preoperative factors, including adenoma volumetry, associated with reduced VA and postoperative improvement of VA over five years after surgery. METHODS: Eighty-seven patients who had primary surgery for NFPA were retrospectively reviewed. Eyes were categorized by best/worse preoperative VA. Ophthalmology review was performed before surgery, at three months, one to two years, and five years post-surgery. RESULTS: Reduced VA in any eye was present in 55%. VA of the worse eye improved in 77% and normalized in 54%. The majority improved within three months. Additional cases with VA improvement were seen at 1–2 years after surgery. No further improvement was seen five years after surgery. Fifty percent of patients with, per definition, normal preoperative VA showed improved VA postoperatively. Tumor height above the sella in the sagittal plane was the best radiological predictor of reduced VA. Volumetry did not add to accuracy. Age, sagittal tumor height and visual field defects were risk factors of preoperative reduced VA. No predictors of postoperative recovery were identified. CONCLUSION: Half of patients with reduced VA recover fully. All patients, independent of age and degree of VA reduction, may improve. No predictors of recovery were found. Early improvement is common and improvement beyond two years is unlikely. The frequency of reduced VA is underestimated. The present results could be of value in pre- and postoperative counseling.
format Online
Article
Text
id pubmed-10668060
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106680602023-08-26 Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery Uvelius, Erik Valdemarsson, Stig Bengzon, Johan Hammar, Björn Siesjö, Peter Brain Spine Article BACKGROUND: Visual acuity (VA) and visual field defects (VF) are evaluated in the preoperative management of non-functioning pituitary adenoma (NFPA). The former is less studied than the latter. RESEARCH QUESTION: To analyze preoperative factors, including adenoma volumetry, associated with reduced VA and postoperative improvement of VA over five years after surgery. METHODS: Eighty-seven patients who had primary surgery for NFPA were retrospectively reviewed. Eyes were categorized by best/worse preoperative VA. Ophthalmology review was performed before surgery, at three months, one to two years, and five years post-surgery. RESULTS: Reduced VA in any eye was present in 55%. VA of the worse eye improved in 77% and normalized in 54%. The majority improved within three months. Additional cases with VA improvement were seen at 1–2 years after surgery. No further improvement was seen five years after surgery. Fifty percent of patients with, per definition, normal preoperative VA showed improved VA postoperatively. Tumor height above the sella in the sagittal plane was the best radiological predictor of reduced VA. Volumetry did not add to accuracy. Age, sagittal tumor height and visual field defects were risk factors of preoperative reduced VA. No predictors of postoperative recovery were identified. CONCLUSION: Half of patients with reduced VA recover fully. All patients, independent of age and degree of VA reduction, may improve. No predictors of recovery were found. Early improvement is common and improvement beyond two years is unlikely. The frequency of reduced VA is underestimated. The present results could be of value in pre- and postoperative counseling. Elsevier 2023-08-26 /pmc/articles/PMC10668060/ /pubmed/38020979 http://dx.doi.org/10.1016/j.bas.2023.102667 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Uvelius, Erik
Valdemarsson, Stig
Bengzon, Johan
Hammar, Björn
Siesjö, Peter
Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery
title Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery
title_full Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery
title_fullStr Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery
title_full_unstemmed Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery
title_short Visual acuity in patients with non-functioning pituitary adenoma: Prognostic factors and long-term outcome after surgery
title_sort visual acuity in patients with non-functioning pituitary adenoma: prognostic factors and long-term outcome after surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668060/
https://www.ncbi.nlm.nih.gov/pubmed/38020979
http://dx.doi.org/10.1016/j.bas.2023.102667
work_keys_str_mv AT uveliuserik visualacuityinpatientswithnonfunctioningpituitaryadenomaprognosticfactorsandlongtermoutcomeaftersurgery
AT valdemarssonstig visualacuityinpatientswithnonfunctioningpituitaryadenomaprognosticfactorsandlongtermoutcomeaftersurgery
AT bengzonjohan visualacuityinpatientswithnonfunctioningpituitaryadenomaprognosticfactorsandlongtermoutcomeaftersurgery
AT hammarbjorn visualacuityinpatientswithnonfunctioningpituitaryadenomaprognosticfactorsandlongtermoutcomeaftersurgery
AT siesjopeter visualacuityinpatientswithnonfunctioningpituitaryadenomaprognosticfactorsandlongtermoutcomeaftersurgery